Biswas Subhrajit, Ghose Sampa
Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India, and Amity Institute of Molecular Medicine and Stem Cell Research, AUUP, Noida, India,
Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Front Biosci (Schol Ed). 2018 Jan 1;10(1):65-100. doi: 10.2741/s501.
Several investigations have revealed that liver diseases exhibit gender biases, but identifying the root causes of such biases has been challenging. Evidence of gender differences in liver function is present from the early stage of embryonic development. The differences in access to care and treatment as well as diagnostic deliberation may affect gender-specific differences in liver disease progression. Apart from the pathogenesis, xenobiotic metabolism, immune responses, gene expressions, mitochondrial function, lipid composition, and enzyme activities also differ in this sexually dimorphic organ. Differences in a social environment and lifestyle of men and women may also be involved in the basic mechanisms underlying the sex-associated differences and protective or aggravating effects of sex hormones during viral infections, alcoholic and non-alcoholic chronic and/or acute mode of liver injuries, carcinogenesis, autoimmune responses, and liver transplantation outcome. We summarized here the recent findings regarding the influence of sex hormones on immune responses underlying the pathology of the liver diseases in humans and animal models.
多项调查显示,肝脏疾病存在性别差异,但确定这些差异的根本原因一直具有挑战性。从胚胎发育早期就存在肝功能性别差异的证据。在获得护理和治疗以及诊断考量方面的差异,可能会影响肝脏疾病进展中的性别特异性差异。除了发病机制外,在这个具有性别二态性的器官中,外源性物质代谢、免疫反应、基因表达、线粒体功能、脂质组成和酶活性也存在差异。男性和女性社会环境和生活方式的差异,也可能参与了病毒感染、酒精性和非酒精性急慢性肝损伤、致癌作用、自身免疫反应以及肝移植结果等过程中,性别相关差异和性激素的保护或加重作用的基本机制。我们在此总结了关于性激素对人类和动物模型中肝脏疾病病理学基础免疫反应影响的最新研究结果。